USP30-Targeting PROTACs

N/A

Report date: 2023/03/03 14:13:39
NME

Base Information

Drug NameUSP30-Targeting PROTACs
Drug Alias NameN/A
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionUbiquitin carboxyl-terminal hydrolase 30 degraders
TargetsUbiquitin carboxyl-terminal hydrolase 30
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUbiquigent Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUbiquigent Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A